カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界の静脈注射（IV）用イブプロフェン市場予測2023-2029：100mg用量、200mg用量、400mg用量、800mg用量

【英語タイトル】Intravenous (IV) Ibuprofen Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23LY8520）・商品コード：MMG23LY8520
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：70
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の静脈注射（IV）用イブプロフェン市場規模と予測を収録しています。・世界の静脈注射（IV）用イブプロフェン市場：売上、2018年-2023年、2024年-2029年
・世界の静脈注射（IV）用イブプロフェン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の静脈注射（IV）用イブプロフェン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「100mg用量」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

静脈注射（IV）用イブプロフェンのグローバル主要企業は、Cumberland Pharmaceuticals、 Alveda Pharmaceuticals、 CSL Limited、 Sandor Medicaids、 PT. Soho Industri Pharmasi、 Germin MED、 Grifols、 Gloria Pharmaceuticals、 Al Nabeel International、 Laboratorios Valmorcaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、静脈注射（IV）用イブプロフェンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の静脈注射（IV）用イブプロフェン市場：タイプ別、2018年-2023年、2024年-2029年
世界の静脈注射（IV）用イブプロフェン市場：タイプ別市場シェア、2022年
・100mg用量、200mg用量、400mg用量、800mg用量

世界の静脈注射（IV）用イブプロフェン市場：用途別、2018年-2023年、2024年-2029年
世界の静脈注射（IV）用イブプロフェン市場：用途別市場シェア、2022年
・疼痛、発熱、炎症

世界の静脈注射（IV）用イブプロフェン市場：地域・国別、2018年-2023年、2024年-2029年
世界の静脈注射（IV）用イブプロフェン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における静脈注射（IV）用イブプロフェンのグローバル売上、2018年-2023年
・主要企業における静脈注射（IV）用イブプロフェンのグローバル売上シェア、2022年
・主要企業における静脈注射（IV）用イブプロフェンのグローバル販売量、2018年-2023年
・主要企業における静脈注射（IV）用イブプロフェンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Cumberland Pharmaceuticals、 Alveda Pharmaceuticals、 CSL Limited、 Sandor Medicaids、 PT. Soho Industri Pharmasi、 Germin MED、 Grifols、 Gloria Pharmaceuticals、 Al Nabeel International、 Laboratorios Valmorca

*************************************************************

・調査・分析レポートの概要
静脈注射（IV）用イブプロフェン市場の定義
市場セグメント
世界の静脈注射（IV）用イブプロフェン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の静脈注射（IV）用イブプロフェン市場規模
世界の静脈注射（IV）用イブプロフェン市場規模：2022年 VS 2029年
世界の静脈注射（IV）用イブプロフェン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの静脈注射（IV）用イブプロフェンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の静脈注射（IV）用イブプロフェン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：100mg用量、200mg用量、400mg用量、800mg用量
静脈注射（IV）用イブプロフェンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：疼痛、発熱、炎症
静脈注射（IV）用イブプロフェンの用途別グローバル売上・予測

・地域別市場分析
地域別静脈注射（IV）用イブプロフェン市場規模 2022年と2029年
地域別静脈注射（IV）用イブプロフェン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Cumberland Pharmaceuticals、 Alveda Pharmaceuticals、 CSL Limited、 Sandor Medicaids、 PT. Soho Industri Pharmasi、 Germin MED、 Grifols、 Gloria Pharmaceuticals、 Al Nabeel International、 Laboratorios Valmorca
...

Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness.
This report aims to provide a comprehensive presentation of the global market for Intravenous (IV) Ibuprofen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous (IV) Ibuprofen. This report contains market size and forecasts of Intravenous (IV) Ibuprofen in global, including the following market information:
Global Intravenous (IV) Ibuprofen Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Intravenous (IV) Ibuprofen Market Sales, 2018-2023, 2024-2029, (MT)
Global top five Intravenous (IV) Ibuprofen companies in 2022 (%)
The global Intravenous (IV) Ibuprofen market was valued at US$ 7250.7 million in 2022 and is projected to reach US$ 14880 million by 2029, at a CAGR of 10.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
100 mg Dose Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Intravenous (IV) Ibuprofen include Cumberland Pharmaceuticals, Alveda Pharmaceuticals, CSL Limited, Sandor Medicaids, PT. Soho Industri Pharmasi, Germin MED, Grifols, Gloria Pharmaceuticals and Al Nabeel International, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Intravenous (IV) Ibuprofen manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intravenous (IV) Ibuprofen Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Intravenous (IV) Ibuprofen Market Segment Percentages, by Type, 2022 (%)
100 mg Dose
200 mg Dose
400 mg Dose
800 mg Dose
Global Intravenous (IV) Ibuprofen Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Intravenous (IV) Ibuprofen Market Segment Percentages, by Application, 2022 (%)
Pain
Fever
Inflammation
Global Intravenous (IV) Ibuprofen Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Intravenous (IV) Ibuprofen Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Intravenous (IV) Ibuprofen revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Intravenous (IV) Ibuprofen revenues share in global market, 2022 (%)
Key companies Intravenous (IV) Ibuprofen sales in global market, 2018-2023 (Estimated), (MT)
Key companies Intravenous (IV) Ibuprofen sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cumberland Pharmaceuticals
Alveda Pharmaceuticals
CSL Limited
Sandor Medicaids
PT. Soho Industri Pharmasi
Germin MED
Grifols
Gloria Pharmaceuticals
Al Nabeel International
Laboratorios Valmorca
Outline of Major Chapters:
Chapter 1: Introduces the definition of Intravenous (IV) Ibuprofen, market overview.
Chapter 2: Global Intravenous (IV) Ibuprofen market size in revenue and volume.
Chapter 3: Detailed analysis of Intravenous (IV) Ibuprofen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Intravenous (IV) Ibuprofen in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Intravenous (IV) Ibuprofen capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Intravenous (IV) Ibuprofen Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Intravenous (IV) Ibuprofen Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Intravenous (IV) Ibuprofen Overall Market Size
2.1 Global Intravenous (IV) Ibuprofen Market Size: 2022 VS 2029
2.2 Global Intravenous (IV) Ibuprofen Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Intravenous (IV) Ibuprofen Sales: 2018-2029
3 Company Landscape
3.1 Top Intravenous (IV) Ibuprofen Players in Global Market
3.2 Top Global Intravenous (IV) Ibuprofen Companies Ranked by Revenue
3.3 Global Intravenous (IV) Ibuprofen Revenue by Companies
3.4 Global Intravenous (IV) Ibuprofen Sales by Companies
3.5 Global Intravenous (IV) Ibuprofen Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Intravenous (IV) Ibuprofen Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Intravenous (IV) Ibuprofen Product Type
3.8 Tier 1, Tier 2 and Tier 3 Intravenous (IV) Ibuprofen Players in Global Market
3.8.1 List of Global Tier 1 Intravenous (IV) Ibuprofen Companies
3.8.2 List of Global Tier 2 and Tier 3 Intravenous (IV) Ibuprofen Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Intravenous (IV) Ibuprofen Market Size Markets, 2022 & 2029
4.1.2 100 mg Dose
4.1.3 200 mg Dose
4.1.4 400 mg Dose
4.1.5 800 mg Dose
4.2 By Type – Global Intravenous (IV) Ibuprofen Revenue & Forecasts
4.2.1 By Type – Global Intravenous (IV) Ibuprofen Revenue, 2018-2023
4.2.2 By Type – Global Intravenous (IV) Ibuprofen Revenue, 2024-2029
4.2.3 By Type – Global Intravenous (IV) Ibuprofen Revenue Market Share, 2018-2029
4.3 By Type – Global Intravenous (IV) Ibuprofen Sales & Forecasts
4.3.1 By Type – Global Intravenous (IV) Ibuprofen Sales, 2018-2023
4.3.2 By Type – Global Intravenous (IV) Ibuprofen Sales, 2024-2029
4.3.3 By Type – Global Intravenous (IV) Ibuprofen Sales Market Share, 2018-2029
4.4 By Type – Global Intravenous (IV) Ibuprofen Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Intravenous (IV) Ibuprofen Market Size, 2022 & 2029
5.1.2 Pain
5.1.3 Fever
5.1.4 Inflammation
5.2 By Application – Global Intravenous (IV) Ibuprofen Revenue & Forecasts
5.2.1 By Application – Global Intravenous (IV) Ibuprofen Revenue, 2018-2023
5.2.2 By Application – Global Intravenous (IV) Ibuprofen Revenue, 2024-2029
5.2.3 By Application – Global Intravenous (IV) Ibuprofen Revenue Market Share, 2018-2029
5.3 By Application – Global Intravenous (IV) Ibuprofen Sales & Forecasts
5.3.1 By Application – Global Intravenous (IV) Ibuprofen Sales, 2018-2023
5.3.2 By Application – Global Intravenous (IV) Ibuprofen Sales, 2024-2029
5.3.3 By Application – Global Intravenous (IV) Ibuprofen Sales Market Share, 2018-2029
5.4 By Application – Global Intravenous (IV) Ibuprofen Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Intravenous (IV) Ibuprofen Market Size, 2022 & 2029
6.2 By Region – Global Intravenous (IV) Ibuprofen Revenue & Forecasts
6.2.1 By Region – Global Intravenous (IV) Ibuprofen Revenue, 2018-2023
6.2.2 By Region – Global Intravenous (IV) Ibuprofen Revenue, 2024-2029
6.2.3 By Region – Global Intravenous (IV) Ibuprofen Revenue Market Share, 2018-2029
6.3 By Region – Global Intravenous (IV) Ibuprofen Sales & Forecasts
6.3.1 By Region – Global Intravenous (IV) Ibuprofen Sales, 2018-2023
6.3.2 By Region – Global Intravenous (IV) Ibuprofen Sales, 2024-2029
6.3.3 By Region – Global Intravenous (IV) Ibuprofen Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Intravenous (IV) Ibuprofen Revenue, 2018-2029
6.4.2 By Country – North America Intravenous (IV) Ibuprofen Sales, 2018-2029
6.4.3 US Intravenous (IV) Ibuprofen Market Size, 2018-2029
6.4.4 Canada Intravenous (IV) Ibuprofen Market Size, 2018-2029
6.4.5 Mexico Intravenous (IV) Ibuprofen Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Intravenous (IV) Ibuprofen Revenue, 2018-2029
6.5.2 By Country – Europe Intravenous (IV) Ibuprofen Sales, 2018-2029
6.5.3 Germany Intravenous (IV) Ibuprofen Market Size, 2018-2029
6.5.4 France Intravenous (IV) Ibuprofen Market Size, 2018-2029
6.5.5 U.K. Intravenous (IV) Ibuprofen Market Size, 2018-2029
6.5.6 Italy Intravenous (IV) Ibuprofen Market Size, 2018-2029
6.5.7 Russia Intravenous (IV) Ibuprofen Market Size, 2018-2029
6.5.8 Nordic Countries Intravenous (IV) Ibuprofen Market Size, 2018-2029
6.5.9 Benelux Intravenous (IV) Ibuprofen Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Intravenous (IV) Ibuprofen Revenue, 2018-2029
6.6.2 By Region – Asia Intravenous (IV) Ibuprofen Sales, 2018-2029
6.6.3 China Intravenous (IV) Ibuprofen Market Size, 2018-2029
6.6.4 Japan Intravenous (IV) Ibuprofen Market Size, 2018-2029
6.6.5 South Korea Intravenous (IV) Ibuprofen Market Size, 2018-2029
6.6.6 Southeast Asia Intravenous (IV) Ibuprofen Market Size, 2018-2029
6.6.7 India Intravenous (IV) Ibuprofen Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Intravenous (IV) Ibuprofen Revenue, 2018-2029
6.7.2 By Country – South America Intravenous (IV) Ibuprofen Sales, 2018-2029
6.7.3 Brazil Intravenous (IV) Ibuprofen Market Size, 2018-2029
6.7.4 Argentina Intravenous (IV) Ibuprofen Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Intravenous (IV) Ibuprofen Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Intravenous (IV) Ibuprofen Sales, 2018-2029
6.8.3 Turkey Intravenous (IV) Ibuprofen Market Size, 2018-2029
6.8.4 Israel Intravenous (IV) Ibuprofen Market Size, 2018-2029
6.8.5 Saudi Arabia Intravenous (IV) Ibuprofen Market Size, 2018-2029
6.8.6 UAE Intravenous (IV) Ibuprofen Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Cumberland Pharmaceuticals
7.1.1 Cumberland Pharmaceuticals Company Summary
7.1.2 Cumberland Pharmaceuticals Business Overview
7.1.3 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Major Product Offerings
7.1.4 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Sales and Revenue in Global (2018-2023)
7.1.5 Cumberland Pharmaceuticals Key News & Latest Developments
7.2 Alveda Pharmaceuticals
7.2.1 Alveda Pharmaceuticals Company Summary
7.2.2 Alveda Pharmaceuticals Business Overview
7.2.3 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Major Product Offerings
7.2.4 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Sales and Revenue in Global (2018-2023)
7.2.5 Alveda Pharmaceuticals Key News & Latest Developments
7.3 CSL Limited
7.3.1 CSL Limited Company Summary
7.3.2 CSL Limited Business Overview
7.3.3 CSL Limited Intravenous (IV) Ibuprofen Major Product Offerings
7.3.4 CSL Limited Intravenous (IV) Ibuprofen Sales and Revenue in Global (2018-2023)
7.3.5 CSL Limited Key News & Latest Developments
7.4 Sandor Medicaids
7.4.1 Sandor Medicaids Company Summary
7.4.2 Sandor Medicaids Business Overview
7.4.3 Sandor Medicaids Intravenous (IV) Ibuprofen Major Product Offerings
7.4.4 Sandor Medicaids Intravenous (IV) Ibuprofen Sales and Revenue in Global (2018-2023)
7.4.5 Sandor Medicaids Key News & Latest Developments
7.5 PT. Soho Industri Pharmasi
7.5.1 PT. Soho Industri Pharmasi Company Summary
7.5.2 PT. Soho Industri Pharmasi Business Overview
7.5.3 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Major Product Offerings
7.5.4 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Sales and Revenue in Global (2018-2023)
7.5.5 PT. Soho Industri Pharmasi Key News & Latest Developments
7.6 Germin MED
7.6.1 Germin MED Company Summary
7.6.2 Germin MED Business Overview
7.6.3 Germin MED Intravenous (IV) Ibuprofen Major Product Offerings
7.6.4 Germin MED Intravenous (IV) Ibuprofen Sales and Revenue in Global (2018-2023)
7.6.5 Germin MED Key News & Latest Developments
7.7 Grifols
7.7.1 Grifols Company Summary
7.7.2 Grifols Business Overview
7.7.3 Grifols Intravenous (IV) Ibuprofen Major Product Offerings
7.7.4 Grifols Intravenous (IV) Ibuprofen Sales and Revenue in Global (2018-2023)
7.7.5 Grifols Key News & Latest Developments
7.8 Gloria Pharmaceuticals
7.8.1 Gloria Pharmaceuticals Company Summary
7.8.2 Gloria Pharmaceuticals Business Overview
7.8.3 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Major Product Offerings
7.8.4 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Sales and Revenue in Global (2018-2023)
7.8.5 Gloria Pharmaceuticals Key News & Latest Developments
7.9 Al Nabeel International
7.9.1 Al Nabeel International Company Summary
7.9.2 Al Nabeel International Business Overview
7.9.3 Al Nabeel International Intravenous (IV) Ibuprofen Major Product Offerings
7.9.4 Al Nabeel International Intravenous (IV) Ibuprofen Sales and Revenue in Global (2018-2023)
7.9.5 Al Nabeel International Key News & Latest Developments
7.10 Laboratorios Valmorca
7.10.1 Laboratorios Valmorca Company Summary
7.10.2 Laboratorios Valmorca Business Overview
7.10.3 Laboratorios Valmorca Intravenous (IV) Ibuprofen Major Product Offerings
7.10.4 Laboratorios Valmorca Intravenous (IV) Ibuprofen Sales and Revenue in Global (2018-2023)
7.10.5 Laboratorios Valmorca Key News & Latest Developments
8 Global Intravenous (IV) Ibuprofen Production Capacity, Analysis
8.1 Global Intravenous (IV) Ibuprofen Production Capacity, 2018-2029
8.2 Intravenous (IV) Ibuprofen Production Capacity of Key Manufacturers in Global Market
8.3 Global Intravenous (IV) Ibuprofen Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Intravenous (IV) Ibuprofen Supply Chain Analysis
10.1 Intravenous (IV) Ibuprofen Industry Value Chain
10.2 Intravenous (IV) Ibuprofen Upstream Market
10.3 Intravenous (IV) Ibuprofen Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Intravenous (IV) Ibuprofen Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Intravenous (IV) Ibuprofen in Global Market
Table 2. Top Intravenous (IV) Ibuprofen Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Intravenous (IV) Ibuprofen Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Intravenous (IV) Ibuprofen Revenue Share by Companies, 2018-2023
Table 5. Global Intravenous (IV) Ibuprofen Sales by Companies, (MT), 2018-2023
Table 6. Global Intravenous (IV) Ibuprofen Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Intravenous (IV) Ibuprofen Price (2018-2023) & (USD/Kg)
Table 8. Global Manufacturers Intravenous (IV) Ibuprofen Product Type
Table 9. List of Global Tier 1 Intravenous (IV) Ibuprofen Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Intravenous (IV) Ibuprofen Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Intravenous (IV) Ibuprofen Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Intravenous (IV) Ibuprofen Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Intravenous (IV) Ibuprofen Sales (MT), 2018-2023
Table 15. By Type - Global Intravenous (IV) Ibuprofen Sales (MT), 2024-2029
Table 16. By Application – Global Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Intravenous (IV) Ibuprofen Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Intravenous (IV) Ibuprofen Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Intravenous (IV) Ibuprofen Sales (MT), 2018-2023
Table 20. By Application - Global Intravenous (IV) Ibuprofen Sales (MT), 2024-2029
Table 21. By Region – Global Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Intravenous (IV) Ibuprofen Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Intravenous (IV) Ibuprofen Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Intravenous (IV) Ibuprofen Sales (MT), 2018-2023
Table 25. By Region - Global Intravenous (IV) Ibuprofen Sales (MT), 2024-2029
Table 26. By Country - North America Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Intravenous (IV) Ibuprofen Sales, (MT), 2018-2023
Table 29. By Country - North America Intravenous (IV) Ibuprofen Sales, (MT), 2024-2029
Table 30. By Country - Europe Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Intravenous (IV) Ibuprofen Sales, (MT), 2018-2023
Table 33. By Country - Europe Intravenous (IV) Ibuprofen Sales, (MT), 2024-2029
Table 34. By Region - Asia Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Intravenous (IV) Ibuprofen Sales, (MT), 2018-2023
Table 37. By Region - Asia Intravenous (IV) Ibuprofen Sales, (MT), 2024-2029
Table 38. By Country - South America Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Intravenous (IV) Ibuprofen Sales, (MT), 2018-2023
Table 41. By Country - South America Intravenous (IV) Ibuprofen Sales, (MT), 2024-2029
Table 42. By Country - Middle East & Africa Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Intravenous (IV) Ibuprofen Sales, (MT), 2018-2023
Table 45. By Country - Middle East & Africa Intravenous (IV) Ibuprofen Sales, (MT), 2024-2029
Table 46. Cumberland Pharmaceuticals Company Summary
Table 47. Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Product Offerings
Table 48. Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 49. Cumberland Pharmaceuticals Key News & Latest Developments
Table 50. Alveda Pharmaceuticals Company Summary
Table 51. Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Product Offerings
Table 52. Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 53. Alveda Pharmaceuticals Key News & Latest Developments
Table 54. CSL Limited Company Summary
Table 55. CSL Limited Intravenous (IV) Ibuprofen Product Offerings
Table 56. CSL Limited Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 57. CSL Limited Key News & Latest Developments
Table 58. Sandor Medicaids Company Summary
Table 59. Sandor Medicaids Intravenous (IV) Ibuprofen Product Offerings
Table 60. Sandor Medicaids Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 61. Sandor Medicaids Key News & Latest Developments
Table 62. PT. Soho Industri Pharmasi Company Summary
Table 63. PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Product Offerings
Table 64. PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 65. PT. Soho Industri Pharmasi Key News & Latest Developments
Table 66. Germin MED Company Summary
Table 67. Germin MED Intravenous (IV) Ibuprofen Product Offerings
Table 68. Germin MED Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 69. Germin MED Key News & Latest Developments
Table 70. Grifols Company Summary
Table 71. Grifols Intravenous (IV) Ibuprofen Product Offerings
Table 72. Grifols Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 73. Grifols Key News & Latest Developments
Table 74. Gloria Pharmaceuticals Company Summary
Table 75. Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Product Offerings
Table 76. Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 77. Gloria Pharmaceuticals Key News & Latest Developments
Table 78. Al Nabeel International Company Summary
Table 79. Al Nabeel International Intravenous (IV) Ibuprofen Product Offerings
Table 80. Al Nabeel International Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 81. Al Nabeel International Key News & Latest Developments
Table 82. Laboratorios Valmorca Company Summary
Table 83. Laboratorios Valmorca Intravenous (IV) Ibuprofen Product Offerings
Table 84. Laboratorios Valmorca Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 85. Laboratorios Valmorca Key News & Latest Developments
Table 86. Intravenous (IV) Ibuprofen Production Capacity (MT) of Key Manufacturers in Global Market, 2021-2023 (MT)
Table 87. Global Intravenous (IV) Ibuprofen Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Intravenous (IV) Ibuprofen Production by Region, 2018-2023 (MT)
Table 89. Global Intravenous (IV) Ibuprofen Production by Region, 2024-2029 (MT)
Table 90. Intravenous (IV) Ibuprofen Market Opportunities & Trends in Global Market
Table 91. Intravenous (IV) Ibuprofen Market Drivers in Global Market
Table 92. Intravenous (IV) Ibuprofen Market Restraints in Global Market
Table 93. Intravenous (IV) Ibuprofen Raw Materials
Table 94. Intravenous (IV) Ibuprofen Raw Materials Suppliers in Global Market
Table 95. Typical Intravenous (IV) Ibuprofen Downstream
Table 96. Intravenous (IV) Ibuprofen Downstream Clients in Global Market
Table 97. Intravenous (IV) Ibuprofen Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Intravenous (IV) Ibuprofen Segment by Type in 2022
Figure 2. Intravenous (IV) Ibuprofen Segment by Application in 2022
Figure 3. Global Intravenous (IV) Ibuprofen Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Intravenous (IV) Ibuprofen Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Intravenous (IV) Ibuprofen Revenue, 2018-2029 (US$, Mn)
Figure 7. Intravenous (IV) Ibuprofen Sales in Global Market: 2018-2029 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Intravenous (IV) Ibuprofen Revenue in 2022
Figure 9. By Type - Global Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Intravenous (IV) Ibuprofen Revenue Market Share, 2018-2029
Figure 11. By Type - Global Intravenous (IV) Ibuprofen Sales Market Share, 2018-2029
Figure 12. By Type - Global Intravenous (IV) Ibuprofen Price (USD/Kg), 2018-2029
Figure 13. By Application - Global Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Intravenous (IV) Ibuprofen Revenue Market Share, 2018-2029
Figure 15. By Application - Global Intravenous (IV) Ibuprofen Sales Market Share, 2018-2029
Figure 16. By Application - Global Intravenous (IV) Ibuprofen Price (USD/Kg), 2018-2029
Figure 17. By Region - Global Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Intravenous (IV) Ibuprofen Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Intravenous (IV) Ibuprofen Revenue Market Share, 2018-2029
Figure 20. By Region - Global Intravenous (IV) Ibuprofen Sales Market Share, 2018-2029
Figure 21. By Country - North America Intravenous (IV) Ibuprofen Revenue Market Share, 2018-2029
Figure 22. By Country - North America Intravenous (IV) Ibuprofen Sales Market Share, 2018-2029
Figure 23. US Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Intravenous (IV) Ibuprofen Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Intravenous (IV) Ibuprofen Sales Market Share, 2018-2029
Figure 28. Germany Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2018-2029
Figure 29. France Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Intravenous (IV) Ibuprofen Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Intravenous (IV) Ibuprofen Sales Market Share, 2018-2029
Figure 37. China Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2018-2029
Figure 41. India Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Intravenous (IV) Ibuprofen Revenue Market Share, 2018-2029
Figure 43. By Country - South America Intravenous (IV) Ibuprofen Sales Market Share, 2018-2029
Figure 44. Brazil Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Intravenous (IV) Ibuprofen Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Intravenous (IV) Ibuprofen Sales Market Share, 2018-2029
Figure 48. Turkey Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Intravenous (IV) Ibuprofen Revenue, (US$, Mn), 2018-2029
Figure 52. Global Intravenous (IV) Ibuprofen Production Capacity (MT), 2018-2029
Figure 53. The Percentage of Production Intravenous (IV) Ibuprofen by Region, 2022 VS 2029
Figure 54. Intravenous (IV) Ibuprofen Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界の静脈注射（IV）用イブプロフェン市場予測2023-2029：100mg用量、200mg用量、400mg用量、800mg用量] (コード：MMG23LY8520)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の静脈注射（IV）用イブプロフェン市場予測2023-2029：100mg用量、200mg用量、400mg用量、800mg用量]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の甲状腺ホルモン市場予測2023-2029：0.025mg、0.05mg、1mg、その他
  • 世界のメシル酸イマチニブ錠市場予測2023-2029：100 mg、400 mg
  • 世界のレストレスレッグス症候群治療市場予測2023-2029：一次性レストレスレッグス症候群、二次性レストレスレッグス症候群
  • 世界の高シュウ酸尿症一次治療薬市場予測2023-2029：ALLN-230、DCR-PHXC、ALN-GO1、その他
  • 世界の閉経後骨粗鬆症治療薬市場予測2023-2029：経口式、皮下注射、静脈注射、その他

    • ◆H&Iグローバルリサーチのお客様（例）◆